Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Alexion Europe Sas

02 3Alexion Pharma Gmbh

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1100mg/11ml

Packaging :

Approval Date : 18/11/2020

Application Number : 20191122000116

Regulatory Info : Approved

Registration Country : Sweden

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/3ml

Packaging :

Approval Date : 18/11/2020

Application Number : 20191122000109

Regulatory Info : Approved

Registration Country : Sweden

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/30ml

Packaging :

Approval Date : 02/07/2019

Application Number : 20180628000034

Regulatory Info : Approved

Registration Country : Sweden

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Injectable Solution

Dosage Strength : 245mg

Packaging :

Approval Date : 31/05/2023

Application Number : 20220216000012

Regulatory Info : Deregistered

Registration Country : Sweden

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomir

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/30ml

Packaging :

Approval Date : 20/01/2020

Application Number : 67278

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomir

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/3ml

Packaging :

Approval Date : 20/01/2020

Application Number : 67278

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomir

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1100mg/11ml

Packaging :

Approval Date : 20/01/2020

Application Number : 67278

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 300MG

Packaging :

Approval Date : 2021-06-11

Application Number : 1191371002

Regulatory Info : Authorized

Registration Country : Spain

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 1100MG

Packaging :

Approval Date : 2021-06-11

Application Number : 1191371003

Regulatory Info : Authorized

Registration Country : Spain

blank